EGFR and lung cancer: With multiple fluorescence enhancement effects, the QW-enhanced plasmonic substrate enables SMLM imaging of phosphorylated epidermal growth factor receptors (EGFRs) in A549 lung cancer cells to quantitatively investigate the inhibition of EGFR tyrosine kinase.